References
- National Institutes of HealthOsteoporosis prevention, diagnosis, and therapyNIH Consens Statement (online)2000171136
- FujiwaraSEpidemiology of osteoporosis in JapanJ Bone Miner Metab200523suppl818315984420
- OrimoHNakamuraTHosoiTJapanese 2011 guidelines for prevention and treatment of osteoporosis – executive summaryArch Osteoporos201271–232023203733
- NojiriSBurgeRTFlynnJAFosterSASowaHOsteoporosis and treatments in Japan: management for preventing subsequent fracturesJ Bone Miner Metab201331436738023536192
- JohnellOKanisJAAn estimate of the worldwide prevalence and disability associated with osteoporotic fracturesOsteoporos Int200617121726173316983459
- ImaiEHorioMWatanabeTPrevalence of chronic kidney disease in the Japanese general populationClin Exp Nephrol200913662163019513802
- JonesCAMcQuillanGMKusekJWSerum creatinine levels in the US population: third National Health and Nutrition Examination SurveyAm J Kidney Dis19983269929999856515
- NishikawaAIshidaTTaketsunaMYoshikiFEnomotoHSafety and effectiveness of daily teriparatide in a prospective observational study in patients with osteoporosis at high risk of fracture in Japan: final reportClin Interv Aging20161191392527462147
- DukasLSchachtEStahelinHBIn elderly men and women treated for osteoporosis a low creatinine clearance of <65 ml/min is a risk factor for falls and fracturesOsteoporos Int200516121683169015933802
- LookerACOrwollESJohnstonCCJrPrevalence of low femoral bone density in older U.S. adults from NHANES IIIJ Bone Miner Res19971211176117689383679
- NickolasTLMcMahonDJShaneERelationship between moderate to severe kidney disease and hip fracture in the United StatesJ Am Soc Nephrol200617113223323217005938
- EnsrudKELuiLYTaylorBCOsteoporotic Fractures Research GroupRenal function and risk of hip and vertebral fractures in older womenArch Intern Med2007167213313917242313
- FriedLFBiggsMLShlipakMGAssociation of kidney function with incident hip fracture in older adultsJ Am Soc Nephrol200718128228617167115
- OrimoHJapanese 2015 Guidelines for Prevention and Treatment of OsteoporosisJapanLife Science Publishing Co., Ltd2015
- MillerPDBone disease in CKD: a focus on osteoporosis diagnosis and managementAm J Kidney Dis201464229030424726630
- BodennerDRedmanCRiggsATeriparatide in the management of osteoporosisClin Interv Aging20072449950718225450
- HodsmanABBauerDCDempsterDWParathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its useEndocr Rev200526568870315769903
- KregeJHWanXTeriparatide and the risk of nonvertebral fractures in women with postmenopausal osteoporosisBone201250116116422036910
- MiyauchiAMatsumotoTSugimotoTTsujimotoMWarnerMRNakamuraTEffects of teriparatide on bone mineral density and bone turnover markers in Japanese subjects with osteoporosis at high risk of fracture in a 24-month clinical study: 12-month, randomized, placebo-controlled, double-blind and 12-month open-label phasesBone201047349350220580870
- WalshJBLemsWFKarrasDEffectiveness of teriparatide in women over 75 years of age with severe osteoporosis: 36-month results from the European Forsteo Observational Study (EFOS)Calcif Tissue Int201290537338322466444
- Forteo® [prescribing information]Kobe, JapanEli Lilly Japan K.K.2014 Available from: https://www.lilly.co.jp/_Assets/pdf/lillyanswers/products/tenpu_for-kit600.pdfAccessed September 30, 2016 Japanese
- MillerPDSchwartzENChenPMisurskiDAKregeJHTeriparatide in postmenopausal women with osteoporosis and mild or moderate renal impairmentOsteoporos Int2007181596817013567
- OrimoHHayashiYFukunagaMDiagnostic criteria for primary osteoporosis: year 2000 revisionJ Bone Miner Metab200119633133711685647
- National Kidney FoundationK/DOQI Clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratificationAm J Kidney Dis200239S1S26611904577
- MatsuoSImaiEHorioMCollaborators developing the Japanese equation for estimated GFRRevised equations for estimated GFR from serum creatinine in JapanAm J Kidney Dis200953698299219339088
- ChenPSatterwhiteJHLicataAAEarly changes in biochemical markers of bone formation predict BMD response to teriparatide in postmenopausal women with osteoporosisJ Bone Miner Res200520696297015883636
- OttSMTherapy for patients with CKD and low bone mineral densityNat Rev Nephrol201391168169224100401
- SatoMVietriJFlynnJAFujiwaraSTreatment for osteoporosis among women in Japan: associations with patient characteristics and patient-reported outcomes in the 2008–2011 Japan National Health and Wellness SurveysJ Osteoporos2014201490915325587485
- GramsMEChowEKSegevDLCoreshJLifetime incidence of CKD stages 3–5 in the United StatesAm J Kidney Dis201362224525223566637
- ModiASajjanSGandhiSChallenges in implementing and maintaining osteoporosis therapyInt J Womens Health2014675976925152632